Citadel Advisors’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-28,712
| Closed | -$37.6K | – | 13741 |
|
|
2025
Q4 | $37.6K | Sell |
28,712
-44,185
| -61% | -$61K | ﹤0.01% | 12146 |
|
|
2025
Q3 | $91.8K | Buy |
+72,897
| New | +$94.2K | ﹤0.01% | 11895 |
|
|
2024
Q4 | – | Sell |
-1,431
| Closed | -$3K | – | 15059 |
|
|
2024
Q3 | $3K | Sell |
1,431
-16,798
| -92% | -$24.9K | ﹤0.01% | 13697 |
|
|
2024
Q2 | $26.3K | Sell |
18,229
-7,943
| -30% | -$11.1K | ﹤0.01% | 12398 |
|
|
2024
Q1 | $37.9K | Buy |
+26,172
| New | +$37.2K | ﹤0.01% | 12453 |
|
|
2023
Q3 | – | Sell |
-15,492
| Closed | -$35.6K | – | 14793 |
|
|
2023
Q2 | $35.6K | Sell |
15,492
-4,094
| -21% | -$9.02K | ﹤0.01% | 12169 |
|
|
2023
Q1 | $42.3K | Sell |
19,586
-21,651
| -53% | -$49.6K | ﹤0.01% | 12376 |
|
|
2022
Q4 | $84.5K | Buy |
41,237
+16,710
| +68% | +$36.9K | ﹤0.01% | 11447 |
|
|
2022
Q3 | $53K | Sell |
24,527
-4,606
| -16% | -$10.7K | ﹤0.01% | 11583 |
|
|
2022
Q2 | $74K | Buy |
+29,133
| New | +$76K | ﹤0.01% | 11658 |
|
|
2022
Q1 | – | Sell |
-24,160
| Closed | -$65K | – | 14210 |
|
|
2021
Q4 | $65K | Buy |
24,160
+11,028
| +84% | +$36.9K | ﹤0.01% | 13091 |
|
|
2021
Q3 | $50K | Sell |
13,132
-53,115
| -80% | -$202K | ﹤0.01% | 13368 |
|
|
2021
Q2 | $282K | Buy |
66,247
+39,330
| +146% | +$169K | ﹤0.01% | 11415 |
|
|
2021
Q1 | $136K | Buy |
+26,917
| New | +$157K | ﹤0.01% | 12160 |
|
|
2020
Q4 | – | Sell |
-13,172
| Closed | -$75.5K | – | 11285 |
|
|
2020
Q3 | $69K | Buy |
+13,172
| New | +$76K | ﹤0.01% | 9471 |
|
|
2020
Q2 | – | Sell |
-20,904
| Closed | -$111K | – | 10238 |
|
|
2020
Q1 | $78K | Sell |
20,904
-6,172
| -23% | -$32.1K | ﹤0.01% | 8802 |
|
|
2019
Q4 | $182K | Sell |
27,076
-8,091
| -23% | -$60.8K | ﹤0.01% | 8255 |
|
|
2019
Q3 | $280K | Sell |
35,167
-2,668
| -7% | -$23.8K | ﹤0.01% | 7653 |
|
|
2019
Q2 | $364K | Buy |
+37,835
| New | +$399K | ﹤0.01% | 7286 |
|
|
2018
Q1 | – | Sell |
-12,605
| Closed | -$126K | – | 8585 |
|
|
2017
Q4 | $82K | Buy |
+12,605
| New | +$83.6K | ﹤0.01% | 7494 |
|
|
2015
Q4 | – | Sell |
-12,751
| Closed | -$36K | – | 9003 |
|
|
2015
Q3 | $36K | Buy |
+12,751
| New | +$43.5K | ﹤0.01% | 7799 |
|
|
2014
Q3 | – | Sell |
-15,273
| Closed | -$31K | – | 8289 |
|
|
2014
Q2 | $31K | Buy |
+15,273
| New | +$29.8K | ﹤0.01% | 7060 |
|
Other funds holding MNOV
EWM
VCM
VFT
Citadel Advisors's MNOV Position: Q1 2026 in Review
Citadel Advisors sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 28,712 shares — an estimated $37.6K sold.
Citadel Advisors first reported a position in MNOV in Q2 2014 and held it in 22 quarters. The position peaked at $364K in Q2 2019. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.
- Citadel Advisors reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 28,712 MediciNova shares in Q1 2026, an estimated $37.6K.
- Citadel Advisors first reported a position in MediciNova in Q2 2014 and held it in 22 quarters.
- Citadel Advisors's MediciNova position peaked at $364K in Q2 2019.
- 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.